Skip to main content
. 2020 Jun 29;5(5):943–950. doi: 10.1016/j.adro.2020.06.023

Table 1.

Patient characteristics

Pneumonitis (grade ≥2) Nonpneumonitis P value
Modality
 Proton 20 62
 Photon 20 58 .855
Sex
 Male 21 52
 Female 19 68 .313
Age (y)
 Mean 68.75 65.94
 SD 9.77 11.11 .231
Stage
 IIA 0 2 .909
 IIB 0 1
 IIIA 23 72
 IIIB 17 44
 IV 0 1
Tumor location
 RUL 15 41 .002
 RML 8 4
 RLL 8 15
 LUL 5 40
 LLL 3 7
 Hilum 1 13
PTV volume
 Proton (Mean ± SD) 546.64 ± 265.54 465.79 ± 279.70 .180
 Photon (mean ± SD) 496.06 ± 317.61 618.45 ± 413.96
Chemo
 Concurrent 37 113
 Sequential 3 7 1.000
Chemo type
 Carboplatin/taxol 22 64 .944
 Cisplatin/etoposide 9 30
 Other 8 26
Smoking status
 Never 9 10 .006
 Former 29 83
 Current 2 27

Abbreviations: LLL = left lower lobe; LUL = left upper lobe; PTV = planning target volume; RLL = right lower lobe; RML = right middle lobe; RP = radiation pneumonitis; RUL = right upper lobe; SD = standard deviation.

All RP patients were ≥2 grade.

Missing 1 pneumonitis patient.